TMO Rasio utang marang kapitalisasi buku Thermo Scientific

thermofisher.com - logo grafis emiten TMO

Thermo Fisher Scientific (TMO) has established a foundation for growth through benchmark management and financial transparency, as confirmed by the current debt-to-book capitalization ratio. The value of 0.73 reflects this status, enabling the efficient sale of laboratory systems and reagents. Despite client budget constraints and the post-pandemic downturn, the company is successfully stabilizing its position in the medical diagnostics market.

TMO Thermo Fisher Scientific: Utang-utang marang nilai buku ing interval 04.07.2022 - 29.10.2026

Rincian analitis perusahaan Thermo Fisher Scientific Inc. (TMO)

- rega saiki lan proyeksi nilai saham:
Rega saham Thermo Fisher Scientific|TMO - Rentang target analis
- data kapitalisasi pasar:
Nilai pasar Thermo Scientific|TMO - Nilai Bisnis
- indikator nilai buku ekuitas:
Aset Bersih saben Siji Saham Thermo Fisher Scientific|TMO - Ekuitas Perusahaan|Rasio Nilai Pasar marang Nilai Buku thermofisher.com|TMO - Gunggung Aset Perusahaan
- indikator total utang lan likuiditas perusahaan:
Rasio Total Utang marang Ekuitas Thermo Fisher Scientific|TMO - Rasio silihan jangka dawa marang modal|Utang jangka cendhak marang modal Thermo Fisher Corp|TMO - Gunggung kewajiban utang perusahaan|Utang-utang marang kapitalisasi buku Thermo Scientific|TMO - Kewajiban jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Thermo Fisher Scientific
Analisis komprehensif perusahaan:Thermo Fisher Scientific TMO
Produk sing diprodhuksi Thermo Fisher Scientific Inc.

This indicator is critical when stress-testing assets to evaluate the issuer's resilience to market shocks. The ratio of total liabilities to the book value of equity, illustrated on this debt-to-book equity chart, determines the degree of financial leverage for Thermo Fisher Scientific (TMO), which remains balanced due to stable cash flows from the sale of indispensable laboratory consumables.

Pesaing Thermo Fisher Scientific (TMO)

Utang-utang marang kapitalisasi buku ABT (Abbott Laboratories)|Utang marang aset resik gehealthcare.com|MTD - Rasio utang marang kapitalisasi buku|WAT (Waters Corp) - Rasio utang marang nilai buku|Techne Corporation (TECH) - Rasio utang marang kapitalisasi buku|Utang-utang marang nilai buku Bruker BioSpin (BRKR)|Rasio utang marang kapitalisasi buku Azenta, Inc.|vareximaging.com (VREX) - Utang-utang marang aset resik|Utang marang nilai buku SMLR (Semler Scientific)|Utang marang modal buku BFLY|Utang-utang marang kapitalisasi buku MLAB (Mesa Labs Corp)|Utang-utang marang aset resik Quantum-Si Corporation (QSI)|Nano-X Imaging Ltd. - Utang-utang marang kapitalisasi buku|quanterix.com (QTRX) - Utang marang nilai buku|MASS (908 Devices) - Utang marang nilai buku|CapsoVision - Rasio utang marang aset resik|Rasio utang marang kapitalisasi buku MaxCyte, Inc|Utang marang nilai buku Rapid Micro (RPID)|Utang-utang marang kapitalisasi buku SEER|HYPR - Utang-utang marang nilai buku|Utang-utang marang kapitalisasi buku FONR (FONAR)|DXR: Rasio utang marang nilai buku|Spectral AI - Utang-utang marang kapitalisasi buku|Utang-utang marang aset resik VivoSim Labs Inc VIVS|ACON: Utang-utang marang kapitalisasi buku|Utang marang nilai buku Akoya Biosciences, Inc.|THMO (ThermoGenesis Holdings) - Utang-utang marang kapitalisasi buku|Utang-utang marang kapitalisasi buku Talis Biomedical Corp|Rasio utang marang kapitalisasi buku T2 Biosystems, Inc (TTOO)